Benign Prostatic Hyperplasia Surgical Treatment Market OverviewThe global benign prostatic hyperplasia surgical treatment market is anticipated to experience steady expansion at an approximate growth ...
Patients with benign prostatic hyperplasia (BPH) with preoperative overactive bladder (OAB) have higher postoperative storage ...
Profound Medical Corp. (NASDAQ:PROF) is one of the best Canadian stocks with huge upside potential. On June 10, Profound Medical announced the successful completion of the first commercial benign ...
2UrbanGirls on MSN
Looking for a safe treatment for prostatitis and BPH? Thermobalancing therapy is just what you need
Thermobalancing therapy is an advanced medical technology known for its effective and safe approach to treating men wi ...
Among middle-aged and older men, a higher percentage of total food weight from ultraprocessed food (UPF) is associated with a higher risk for incident benign prostatic hyperplasia (BPH), according to ...
Company’s prospective, multi-center 240-patient, pivotal randomized controlled trial (RCT) earns AUA “Practice-changing, Paradigm-shifting Clinical Trials in Urology (P2s)” designation at conference’s ...
TORONTO, June 10, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (PROF) (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets ...
Hosted on MSN
Struggling with urinary problems? What men should know about benign prostate hyperplasia
Struggling with urinary incontinence can affect your daily life. One of the common causes of such a condition in men is benign prostatic hyperplasia (BPH). It is a condition in which the prostate ...
GREENBRAE, Calif.--(BUSINESS WIRE)--MarinHealth Medical Center (MHMC) announced today that its surgeons have performed the first Aquablation procedures to treat benign prostatic hyperplasia (BPH).
The MarketWatch News Department was not involved in the creation of this content. SUNNYVALE, Calif., March 16, 2026 (GLOBE NEWSWIRE) -- Prodeon Medical, a privately held medical device company focused ...
TORONTO, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (PROF) (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets ...
Prodeon Medical, a medical device company developing minimally invasive treatments for benign prostatic hyperplasia (BPH), today announces that three scientific abstracts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results